-+ 0.00%
-+ 0.00%
-+ 0.00%

Dr Reddy's Laboratories Q1 EPS $0.20 Beats $0.19 Estimate, Sales $997.000M Beat $950.920M Estimate

Benzinga·07/23/2025 11:23:12
Listen to the news
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.19 by 5.26 percent. This is unchanged from the same period last year. The company reported quarterly sales of $997.000 million which beat the analyst consensus estimate of $950.920 million by 4.85 percent. This is a 8.38 percent increase over sales of $919.880 million the same period last year.